• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 129-143 of 326 results

No. 2-9

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-9 (N.D.W.Va. Mar. 18, 2022)

cite Cite Document
Analyze

No. 2-11

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-11 (N.D.W.Va. Mar. 18, 2022)

cite Cite Document
Analyze

No. 2-17

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-17 (N.D.W.Va. Mar. 18, 2022)

cite Cite Document
Analyze

No. 2-2

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-2 (N.D.W.Va. Mar. 18, 2022)

cite Cite Document
Analyze

OZEMPIC

Docket 209637, Orange Book (Dec. 5, 2017)

cite Cite Docket
Analyze

No. 25-3

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 25-3 (N.D.W.Va. May. 11, 2022)

cite Cite Document
Analyze

No. 25-2

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 25-2 (N.D.W.Va. May. 11, 2022)

cite Cite Document
Analyze

No. 25-5

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 25-5 (N.D.W.Va. May. 11, 2022)

cite Cite Document
Analyze

No. 25-1

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 25-1 (N.D.W.Va. May. 11, 2022)

cite Cite Document
Analyze

No. 25-7

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 25-7 (N.D.W.Va. May. 11, 2022)

cite Cite Document
Analyze

No. 25-6

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 25-6 (N.D.W.Va. May. 11, 2022)

cite Cite Document
Analyze

No. 25-4

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 25-4 (N.D.W.Va. May. 11, 2022)

cite Cite Document
Analyze

No. 22-9

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-9 (N.D.W.Va. May. 6, 2022)

cite Cite Document
Analyze

No. 22-5

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-5 (N.D.W.Va. May. 6, 2022)

cite Cite Document
Analyze

No. 22-3

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-3 (N.D.W.Va. May. 6, 2022)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 9 10 11 12 13 ... >>